Trexquant Investment’s Mirum Pharmaceuticals MIRM Stock Holding History

Trexquant Investment’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.25M	Buy	+53,349	New	+$5.36M	0.04%	628
2025 Q4	–	Sell	-109,959	Closed	-$8.06M	–	1799
2025 Q3	$8.06M	Buy	109,959 +5,656	+5%	+$360K	0.08%	371
2025 Q2	$5.31M	Buy	+104,303	New	+$4.64M	0.06%	508
2021 Q1	–	Sell	-13,734	Closed	-$240K	–	1326
2020 Q4	$240K	Buy	+13,734	New	+$270K	0.03%	809
2020 Q3	–	Sell	-17,282	Closed	-$336K	–	1420
2020 Q2	$336K	Buy	+17,282	New	+$289K	0.02%	821

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Trexquant Investment's MIRM Position: Q2 2026 in Review

Trexquant Investment opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 53,349 shares worth $6.25M. The stake represents 0.04% of the portfolio and ranks #628 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in MIRM as recently as Q3 2025.

Trexquant Investment first reported a position in MIRM in Q2 2020 and has held it in 5 quarters since. The position peaked at $8.06M in Q3 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Trexquant Investment held 53,349 shares of Mirum Pharmaceuticals worth $6.25M as of Q2 2026.
Mirum Pharmaceuticals was a new Trexquant Investment position in Q2 2026.
Mirum Pharmaceuticals made up 0.04% of Trexquant Investment's portfolio in Q2 2026, its #628 holding.
Trexquant Investment first reported a position in Mirum Pharmaceuticals in Q2 2020 and has held it in 5 quarters since.
Trexquant Investment's Mirum Pharmaceuticals position peaked at $8.06M in Q3 2025.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.